GBI Research Market Research Reports

Title published price

Genetic Ophthalmology Disorders Drug Development Pipeline Review, 2017

By GBI Research

Summary Juvenile macular degeneration is a series of inherited eye disorders that affects children and young adults, with the most common form being Stargardt disease, an inherited autosomal recessive syndrome.There are a ...

01-Aug-2017 $3995

Hepatitis Drug Development Pipeline Review, 2017

By GBI Research

Summary Hepatitis is a contagious viral infection affecting the liver, which may spread on contact with infected blood. It may be a mild condition or may extend over a longer span of time leading to various complications. ...

01-Aug-2017 $3995

Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017

By GBI Research

Summary Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity and impulsiveness, with symptoms including disorganized work habits, procrastination and ...

01-Aug-2017 $3995

Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors

By GBI Research

Summary Oncology comprises a large and diverse group of indications, encompassing virtually all sites and tissues in the human body. The diseases are characterized by abnormal cell proliferation, which is followed by local ...

13-Jul-2017 $4995

Pain Drug Development Pipeline Review, 2017

By GBI Research

Summary This report provides an overview of the pain pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Osteoarth ...

01-Jul-2017 $3995

Skeletal Disease Drug Development Pipeline Review, 2017

By GBI Research

Summary This report provides an overview of the skeletal disease pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development f ...

01-Jul-2017 $3995

Transplantation Drug Development Pipeline Review, 2017

By GBI Research

Summary This report provides an overview of the transplantation pipeline landscape, specifically covering drugs used to prevent and treat organ rejection and graft-versus-host disease. The report provides comprehensive inf ...

01-Jul-2017 $3995

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

By GBI Research

Summary Colorectal cancer (CRC) originates in either the colon or the rectum. It is one of the most common types of cancers, and is the third most common cancer among men and the second most common in women (ACS, 2017a; Fe ...

01-Jul-2017 $4995

Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis

By GBI Research

Summary Dermatology is a highly diverse therapy area that deals with diseases of the skin, hair and nails. Over 3,000 types of dermatological conditions are thought to exist, ranging from the autoimmune disorder psoriasis ...

01-Jul-2017 $4995

Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse

By GBI Research

Summary Pain can be classified into three main categories. Nociceptive pain involves the activation of nociceptors - neurons specialized in transmitting information regarding pain that signal to the central nervous system ...

01-Jun-2017 $4995

Frontier Pharma: Dermatology - Intracellular Signal Transducers and Cytokine Signaling Molecules Dominate Pipeline and First-in-Class Innovation

By GBI Research

Summary Dermatology is a highly diverse therapy area that deals with diseases of the skin, hair and nails. Over 3,000 distinct dermatological conditions are thought to exist, ranging from rare autoimmune disorders such as ...

01-Jun-2017 $6995

Asthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market

By GBI Research

Asthma is a common chronic inflammatory disease of the airways. It is characterized by recurrent attacks of breathlessness and wheezing that vary in frequency and severity from patient to patient. Variable degrees of airflow obstruction, bronchial ...

01-Jun-2017 $4995

Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation

By GBI Research

Summary Liver plays various vital roles within the body, including the removal of toxins from the blood, the production of bile to help digest fat and substances to help blood clot, in addition to making, storing and relea ...

01-Jun-2017 $6995

Renal Cluster Drug Development Pipeline Review, 2017

By GBI Research

Renal Cluster Drug Development Pipeline Review, 2017 Summary This report provides an overview of the renal cluster pipeline landscape. The report provides comprehensive information on the therapeutics under development and key play ...

11-May-2017 $3995

Women's Health Cluster Drug Development Pipeline Review, 2017

By GBI Research

Women's Health Cluster Drug Development Pipeline Review, 2017 Summary This report provides an overview of the women's health pipeline landscape. The report provides comprehensive information on the therapeutics under development an ...

10-May-2017 $3995

Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017

By GBI Research

Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017 Summary This report provides an overview of the toxicology pipeline landscape. The report provides comprehensive information on the therapeutic ...

09-May-2017 $3995

CNS Cluster Addiction Drug Development Pipeline Review, 2017

By GBI Research

CNS Cluster Addiction Drug Development Pipeline Review, 2017 Summary This report provides an overview of the CNS Clusters pipeline landscape. The report provides comprehensive information on the therapeutics under development, and ...

08-May-2017 $3995

Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017

By GBI Research

Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017 Summary This report provides an overview of the genetic disorders pipeline landscape. The report provides comprehensive information on the therapeut ...

08-May-2017 $3995

Frontier Pharma: First-in-Class Innovation in Hematological Cancers - Cytokine Signaling and Kinase Targeted Immunotherapies Dominate a Large and Highly Versatile Pipeline

By GBI Research

Summary Hematological cancer describes a group of malignancies that affect the blood, lymph nodes and bone marrow. The three main types are leukemia, lymphoma and myeloma. The American Cancer Society (ACS) predicts that in ...

03-May-2017 $6995

Frontier Pharma: Alzheimer’s Disease and Associated Indications - Exceptional Level of First-in-Class Innovation within AD, and Diverse Range of Therapies in Development for Disorders Such as Anxiety and Depression

By GBI Research

Summary Alzheimer’s disease (AD) is the most common form of dementia - a generalized term used to describe loss of memory and other mental abilities that are severe enough to interfere with daily activities. Symptoms ...

01-May-2017 $6995